Xu, Meng
Xu, Teng
Li, Jingwen
Wang, An
Wang, Shuwei
Wu, Shi
Cai, Yida
Zhou, Yi
Qin, Xiaohua
Huang, Haihui
Funding for this research was provided by:
Major Research and Development Project of Innovative Drugs, Ministry of Science and Technology, China (2017ZX09304005-002)
Article History
Received: 12 October 2025
Accepted: 6 February 2026
First Online: 26 February 2026
Declarations
:
: The study protocol was approved by the Institutional Review Board of Huashan Hospital (approval number: 2021-038). The study was conducted according to the principles of the Declaration of Helsinki (2013). All participants provided written informed consent.
: Not applicable.
: The authors declare no competing interests.